| A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death AD Garg, DV Krysko, T Verfaillie, A Kaczmarek, GB Ferreira, T Marysael, ... The EMBO journal 31 (5), 1062-1079, 2012 | 850 | 2012 |
| Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer M Wachowska, A Muchowicz, M Firczuk, M Gabrysiak, M Winiarska, ... Molecules 16 (5), 4140-4164, 2011 | 328 | 2011 |
| Latent LytM at 1.3 Å resolution SG Odintsov, I Sabala, M Marcyjaniak, M Bochtler Journal of molecular biology 335 (3), 775-785, 2004 | 153 | 2004 |
| Crystal structures of active LytM M Firczuk, A Mucha, M Bochtler Journal of molecular biology 354 (3), 578-590, 2005 | 122 | 2005 |
| PDT-induced inflammatory and host responses M Firczuk, D Nowis, J Gołąb Photochemical & Photobiological Sciences 10 (5), 653-663, 2011 | 115 | 2011 |
| Similar active sites in lysostaphins and D‐Ala‐D‐Ala metallopeptidases M Bochtler, SG Odintsov, M Marcyjaniak, I Sabala Protein science 13 (4), 854-861, 2004 | 91 | 2004 |
| Folds and activities of peptidoglycan amidases M Firczuk, M Bochtler FEMS microbiology reviews 31 (6), 676-691, 2007 | 90 | 2007 |
| Typical and atypical inducers of lysosomal cell death: a promising anticancer strategy A Domagala, K Fidyt, M Bobrowicz, J Stachura, K Szczygiel, M Firczuk International journal of molecular sciences 19 (8), 2256, 2018 | 80 | 2018 |
| GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy M Firczuk, M Gabrysiak, J Barankiewicz, A Domagala, D Nowis, M Kujawa, ... Cell Death & Disease 4 (7), e741-e741, 2013 | 69 | 2013 |
| Statins impair glucose uptake in tumor cells A Malenda, A Skrobanska, T Issat, M Winiarska, J Bil, B Oleszczak, ... Neoplasia 14 (4), 311-323, 2012 | 66 | 2012 |
| Approaches to improve photodynamic therapy of cancer M Firczuk, M Winiarska, A Szokalska, M Jodlowska, M Swiech, ... Front Biosci 16 (1), 208-24, 2011 | 58 | 2011 |
| Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents M Bajor, AO Zych, A Graczyk-Jarzynka, A Muchowicz, M Firczuk, ... British Journal of Cancer 119 (7), 873-884, 2018 | 57 | 2018 |
| Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma A Trzeciecka, S Klossowski, M Bajor, R Zagozdzon, P Gaj, A Muchowicz, ... Oncotarget 7 (2), 1717, 2015 | 56 | 2015 |
| Statins impair glucose uptake in human cells D Nowis, A Malenda, K Furs, B Oleszczak, R Sadowski, J Chlebowska, ... BMJ Open Diabetes Research and Care 2 (1), e000017, 2014 | 56 | 2014 |
| Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy A Domagala, J Stachura, M Gabrysiak, A Muchowicz, R Zagozdzon, ... BMC cancer 18, 1-10, 2018 | 54 | 2018 |
| HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies M Bobrowicz, M Dwojak, B Pyrzynska, J Stachura, A Muchowicz, ... Blood, The Journal of the American Society of Hematology 130 (14), 1628-1638, 2017 | 51 | 2017 |
| Peptidoglycan amidase MepA is a LAS metallopeptidase M Marcyjaniak, SG Odintsov, I Sabala, M Bochtler Journal of Biological Chemistry 279 (42), 43982-43989, 2004 | 51 | 2004 |
| Mechanisms of immune evasion in acute lymphoblastic leukemia A Pastorczak, K Domka, K Fidyt, M Poprzeczko, M Firczuk Cancers 13 (07), 1536, 2021 | 48 | 2021 |
| Studies toward novel peptidomimetic inhibitors of thioredoxin–thioredoxin reductase system S Kłossowski, A Muchowicz, M Firczuk, M Swiech, A Redzej, J Golab, ... Journal of medicinal chemistry 55 (1), 55-67, 2012 | 47 | 2012 |
| PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress M Klopotowska, M Bajor, A Graczyk-Jarzynka, A Kraft, Z Pilch, A Zhylko, ... Cancer immunology research 10 (2), 228-244, 2022 | 46 | 2022 |
Jakub GolabMedical University of Warsaw, PolandVerified email at wum.edu.pl
